|
|
|
|
Scorpius Holdings inc (NYSEAMER: SCPX) |
|
Price: $0.1548
$0.00 
-1.401%
|
| Day's High:
| $0.1599
| Week Perf:
| -3.43 %
|
| Day's Low: |
$ 0.15 |
30 Day Perf: |
-42.67 % |
| Volume (M): |
96 |
52 Wk High: |
$ 49.20 |
| Volume (M$): |
$ 15 |
52 Wk Avg: |
$5.67 |
| Open: |
$0.15 |
52 Wk Low: |
$0.14 |
|
|
| Market Capitalization (Millions $) |
1 |
| Shares
Outstanding (Millions) |
7 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
5 |
| Net Income (TTM) (Millions $) |
-24 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
1 |
Scorpius Holdings Inc
Company Address: 627 Davis Drive, Suite 300 Morrisville 27560 NC
Company Phone Number: 240-7133 Stock Exchange / Ticker: NYSEAMER SCPX
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Shares
Published Fri, Jan 17 2025 8:13 PM UTC
Scorpius Holdings, Inc., an integrated contract development and manufacturing organization (CDMO) based in Durham, North Carolina, has canceled its previously announced 1-for-20 reverse stock split following a swift reconsideration by its Board of Directors. The announcement, made on January 17, 2025, has raised eyebrows among investors who had only recently been informed of...
|
| Shares
Published Thu, Jan 16 2025 9:05 PM UTC
Scorpius Holdings Boosts Compliance Efforts with 1-for-20 Reverse Stock Split: A Strategic Move Amid Market ChallengesIn a significant move aimed at strengthening its market presence, Scorpius Holdings, Inc. (NYSE American: SCPX), a prominent integrated contract development and manufacturing organization (CDMO), announced on January 16, 2025, that its Board of Directors has ...
|
| Product Service News
Published Tue, Nov 19 2024 12:30 PM UTC
As the biotechnology sector pushes for increased domestic capacity and innovation, Scorpius Holdings, Inc. (NYSE American: SCPX) has made significant strides with the launch of its new business unit, Scorpius Ventures. This initiative aims to support up-and-coming biotech companies through a flexible equity-based onshoring model, which aligns closely with the s of the BIOSE...
|
| Partnership
Published Mon, Nov 4 2024 12:31 PM UTC
In a significant move set to reshape the landscape of biopharmaceutical manufacturing, Scorpius Holdings, Inc. (NYSE American: SCPX) recently announced a strategic partnership with Celltheon Corporation, a leading U.S.-based cell line development company. This collaboration underscores Scorpius Holdings commitment to expanding its technological capabilities and offering enh...
|
| Management Announcement
Published Thu, Oct 31 2024 11:30 AM UTC
In a strategic move aimed at bolstering its financial health, Scorpius Holdings Inc. has announced the implementation of significant cost savings measures projected to save the company over $2 million annually. This decision follows a troubling financial trajectory, during which Scorpius recorded a cumulative net loss of $28 million in the 12 months ending in the second quar...
|
| Per Share |
Current |
| Earnings (TTM) |
-5429.43 $ |
| Revenues (TTM) |
0.74 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.68 $
|
| Book Value |
3.48 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-5429.43 $
|
| Revenues (TTM) |
0.74 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.68 $
|
| Book Value |
3.48 $ |
| Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
